We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Breath Test Aids Diagnosis of Delayed Gastric Emptying

By HospiMedica International staff writers
Posted on 13 Apr 2015
A new noninvasive test for delayed gastric emptying, also known as gastroparesis, can be performed in a general clinical setting and does not require radioactive material.

The Gastric Emptying Breath Test (GEBT) is designed to show how fast the stomach empties solids by measuring carbon dioxide (CO2) in a patient’s breath. More...
Patients have baseline breath tests at the beginning of the four-hour test; they then eat a test meal that includes a scrambled egg-mix and Spirulina platensis, a protein enriched with carbon-13, a naturally existing non-radioactive form of carbon-12 which can be measured in breath samples. Both carbon-12 and a very small amount of carbon-13 are normally found in exhaled CO2.

By adding carbon-13 to the test meal, the GEBT can determine how fast the stomach empties the meal by measuring the ratio of carbon-13 to carbon-12 collected in breath samples at multiple time points after the meal is consumed. Clinical data from 115 participants who underwent a gastric emptying test with both the GEBT and gastric scintigraphy (the standard of care for measuring gastric emptying) showed a 73%–97% match between the test results, depending when measured during the test. The GEBT is manufactured by Advanced Breath Diagnostics (Brentwood, TN, USA), and has been approved by the US Food and Drug Administration (FDA; Silver Spring, MD, USA).

“The GEBT is another option for aiding in the diagnosis of gastroparesis,” said Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health (CADR). “It can be performed in any clinical setting since it does not require the health care professionals administering the test to undergo special training or to take special precautions related to radiation emitting compounds.”

Gastroparesis is a disorder that slows or stops the movement of food from the stomach to the small intestine due to damage to the vagus nerve, causing improper contraction of the muscles of the stomach and small intestine. It is often the result of intestinal surgery, neurological diseases such as Parkinson’s disease and multiple sclerosis (MS), or high blood glucose levels due to diabetes. If left untreated, gastroparesis can lead to severe dehydration due to persistent vomiting, difficulty managing blood sugar levels in diabetics, and malnutrition due to poor absorption of nutrients or low caloric intake.

Related Links:

US Food and Drug Administration



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.